Email: cspc@cspc.cn
News
News Center
Mar. 15
2024
Two Studies of CSPC Presented at the International Stroke Conference
Feb. 21
Phase III Study of CSPC's Prusogliptin Tablets Published
Latest Research Results of CSPC's Duomeisu Presented at SABCS
CSPC TRACE 2 Study Listed in 2023 Top Ten Stroke Star Studies
First Human Study of CSPC's SYS6002 Presented at ASCO-GU
Feb. 07
VOLUNTARY ANNOUNCEMENT-INDICATION FOR ACUTE ISCHEMIC STROKE OF MINGFULE (明復樂®) (RECOMBINANT HUMAN TNK TISSUE-TYPE PLASMINOGEN ACTIVATOR FOR INJECTION) OBTAINS M
Contact Us
Phone:
+86 311 8703 7015
Email:
cspc@cspc.cn
Products
Science
About Us
